Central Garden & Pet Taps Veteran Kay Schwichtenberg for Board Seat

WALNUT CREEK, CA – February 12, 2026 – Central Garden & Pet Company (NASDAQ: CENT, CENTA) has announced a significant addition to its leadership, appointing former long-time executive Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026. The move is being interpreted by industry watchers as a strategic maneuver to leverage deep institutional knowledge and bolster the company’s focus on its crucial animal health segment.

Schwichtenberg, who retired from the company in February 2023, is no stranger to Central's inner workings. Her career includes a remarkable 29 years with the pet and garden giant, culminating in her role as Executive Vice President, Animal & Public Health. This appointment brings a veteran with over four decades of industry experience back into the fold at a pivotal time for the company as it navigates a challenging consumer market and executes a multi-year simplification strategy.

A Strategic Return to the Fold

The decision to appoint a recently retired executive to the board is a clear signal of the value the company places on deep-seated expertise. Schwichtenberg's tenure saw her in several key leadership positions, including President & CEO of Central Life Sciences and President of Wellmark International, giving her an unparalleled perspective on the company's operations, culture, and strategic evolution.

In the official announcement, Bill Brown, Chairman of the Board, underscored this value. “Kay brings deep leadership experience across consumer products and animal health, along with a strong understanding of Central and our businesses,” he stated. “Her perspective as an operator and executive will be a valuable addition to the Board as we continue to focus on growth, innovation, and long-term value creation.”

This deep understanding is particularly relevant to Central's current strategic priorities. The company is in the midst of a significant “Cost and Simplicity” agenda, a multi-year effort aimed at streamlining its product portfolio, consolidating facilities, and reducing administrative costs. Having a board member with intimate, ground-level knowledge of the company’s historical complexities and operational nuances could prove invaluable in guiding this transformation toward greater efficiency and profitability. Her return provides a unique blend of historical context and high-level strategic oversight, ensuring that restructuring efforts are both ambitious and grounded in operational reality.

Bolstering a Key Growth Engine: Animal Health

Schwichtenberg’s appointment does more than just bring back a familiar face; it strategically reinforces Central’s commitment to the animal health sector, a market experiencing explosive growth. The global pet care market, valued at over $273 billion in 2025, is projected to soar past $427 billion by 2032. This growth is fueled by powerful trends like the “humanization” of pets, where owners increasingly view their animals as family members and invest heavily in their health and wellness.

The animal health market itself is forecast to reach nearly $80 billion in 2026, with a strong compound annual growth rate projected for the next decade. Consumers are driving demand for premium nutrition, preventive care, and advanced wellness products—all areas where Schwichtenberg has extensive experience. Her leadership as the former EVP of Animal & Public Health positions her perfectly to guide Central’s strategy in this booming segment.

Central's recent performance underscores the importance of this focus. In the first quarter of fiscal 2026, the company’s Pet segment saw net sales increase by 4% to $427 million, with operating income growing to $51 million. Schwichtenberg's expertise will be crucial in sustaining this momentum and navigating potential headwinds, such as the projected $20 million in tariff impacts that are expected to primarily affect the Pet segment in fiscal 2026. Her deep industry connections, including a past chairmanship of the influential American Pet Products Association (APPA), further enhance her ability to provide critical market insights and strategic guidance.

Navigating a Dynamic Consumer Landscape

While Schwichtenberg’s background is heavily weighted in animal health, her broad executive experience is vital for overseeing a diversified company like Central Garden & Pet, which generated $3.1 billion in net sales in fiscal 2025. The company’s portfolio includes market-leading brands across both pet and garden aisles, from Nylabone and Aqueon to Pennington and Sevin.

The garden industry is also undergoing its own transformation, driven by a new wave of younger, environmentally conscious consumers. Trends for 2026 point toward increased spending by Gen Y and Gen Z, a focus on regenerative and sustainable practices, and a boom in small-space gardening. A seasoned executive like Schwichtenberg, who has navigated decades of shifting consumer behavior, brings a steady hand to the board as it guides the company's response to these evolving market dynamics across all its businesses.

This experience is especially critical as Central’s management has described the fiscal 2026 outlook as “extremely challenging,” citing tariff pressures and low consumer confidence. The ability to balance long-term strategic investments in innovation with short-term operational discipline will be paramount. Schwichtenberg’s appointment adds a layer of seasoned judgment and proven operational acumen to a board tasked with steering the company through this uncertain economic climate.

Her role as an elected Life Director on the University of Illinois Foundation Board, while non-voting, demonstrates a continued commitment to leadership and institutional development. This, combined with her extensive corporate and industry-wide experience, positions her as a powerful asset. The appointment is a clear, strategic move by Central Garden & Pet, blending the wisdom of a proven veteran with a sharp focus on the future growth drivers of its core markets.